🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

1/ 🔥Our 🆕 Clinical Lung Cancer Brief Report on 1L testing & management in mNSCLC is out! With multiple frontline treatments, it's a complex landscape! Enjoyed collaborating w/ mentee Arthi Sridhar & mentor H. Jack West, MD, FASCO. Key insights👇🏽, a 🧵: ⁦OncoAlert⁩ sciencedirect.com/science/articl…

We need more prospective bio marker studies, particularly to study the role of ct DNA MRD. Tic Tac Toe study is interesting !

🩸#ASCO24 Minimal Residual Disease #MRD Series🔥 📢#8078 #LCSM 🎙️Dr. James M. Isbell Max Diehn, MD/PhD 🧬SNV-based CAPP-Seq 🧬Phased variant-based PhasED-Seq Foresight Diagnostics Inc. 🎯Median LOD95: 1 ppm (PhasED-Seq), 84 ppm (CAPP-Seq) #liquidbiopsy OncoAlert ASCO meetings.asco.org/abstracts-pres…

Lighting tonight in partnership with @mskcancercenter in Honor of MSK’s 140th Anniversary and the ‘NYC for MSK’ Campaign Text CONNECT to 274-16 to get alerts on our Lights! Watch tonight's lighting here: esbo.nyc/xm5 📷: kingy27nyc/IG

🚨It's Friday and time for another FDA approval! 👉FDA grants accelerated approval to adagrasib + cetuximab for KRAS G12C-mutated colorectal cancer #Precisionmedicine Sarah Cannon Docs Bristol Myers Squibb 🧬🎯 Link to FDA approval fda.gov/drugs/resource… Link to NEJM

Please join me and Dr. Jonathan Goldman as we discuss important updates in EGFR biomarker testing and treatment for advanced and early-stage NSCLC. EGFR Resisters USCAP

Today, we celebrate the anniversary of the monumental marriage equality ruling of Obergefell v. Hodges. This case moved our country forward, and was made possible because of the courageous couples and advocates in the LGBTQI+ community who fought for these hard-won rights.

Application are open for the ‘26-‘27 #Cytopathology fellowship MSK Department of Pathology & Laboratory Medicine. We offer high volume exposure to diverse specimens, hands on training in US-guided FNA & dedicated research time Learn more & apply @ ➡ bit.ly/3oxqTR5 DM me with ?? or for more info.

(Unofficial) IASLC Academy meet up is already happening! So grateful for these two physician friends of mine! Soo-Ryum (Stew) Yang MD Fawzi Abu Rous, MD #WCLC24

Please join me and Dr. Jamie Chaft as we explore the latest updates in actionable biomarkers in early-stage NSCLC this Monday, September 9, 2024 at 12:30 PM PDT (Room: 33ABC) #WCLC24

Please vote for our case!! You know it’s a good case when you have a multidisciplinary collaboration between MD Anderson and Memorial Sloan Kettering! 🙏🏻🫁🧬💊🔬

Please join us tomorrow morning, November 13 at 11 am ET for the ISIMM Web monthly webinar. Soo-Ryum (Stew) Yang MD from MSK Department of Pathology & Laboratory Medicine is presenting "Predictive Immunohistochemical Biomarkers in NSCLC." Register here: us02web.zoom.us/webinar/regist… Share widely!

One of the most popular webinars in our on-demand education catalog is about oncogenic RET fusions and features speaker Soo-Ryum (Stew) Yang MD of Memorial Sloan Kettering Cancer Center. It's free for AMP members, $29 for nonmembers and offers continuing education credit: educate.amp.org/local/catalog/…

Join Tom Newsom-Davis, Soo-Ryum (Stew) Yang MD, & me for Medscape Oncology’s Live Event! 🎙️Educating, Empowering, & Engaging: A Focus on HER2-Activating Mutations in NSCLC 📅 Saturday, 2/22 ⏰ 7–8 AM PT 📍 Hyatt Regency Huntington Beach events.medscapelive.org/ereg/newreg.ph…

Final day of #TTLC25! ☕ Kick off your morning in the Mariner’s Ballroom as we dive into all things HER2+ NSCLC!! MedscapeLIVE Medscape Oncology Tom Newsom-Davis Soo-Ryum (Stew) Yang MD IASLC

What should young patients ask about their lung cancer pathology? Dr. Soo-Ryum (Stew) Yang MD breaks it down at CURE Today’s FIRST Young-Onset Lung Cancer Summit. Don’t miss it—join us! Register below👇🏽 globalmeet.webcasts.com/starthere.jsp?…